YANKCOM Partnership »

AstraZeneca shares owned by YANKCOM Partnership

Quarter-by-quarter ownership of AstraZeneca (AZN) shares owned by YANKCOM Partnership from 13F filings

Historical chart of YANKCOM Partnership investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by YANKCOM Partnership consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by YANKCOM Partnership

Quarter filed Position value Share count Share price at filing
2025-12-31 $31k 342 91.93

More positions owned by YANKCOM Partnership

Vanguard FTSE Developed Markets ETF Van Ftse Dev Mkt (VEA)
Vanguard Index Funds S&P 500 ETF S&p 500 Etf Shs (VOO)
Schwab Strategic Tr US Large-Cap Value ETF Us Lcap Va Etf (SCHV)
iShares Tr S&P Midcap 400 ETF Core S&p Mcp Etf (IJH)
iShares Tr Russell Top 200 Growth ETF Rus Tp200 Gr Etf (IWY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Inc Cap Stock Cl A Cap Stk Cl A (GOOGL)
Vanguard FTSE Emerging Markets ETF Ftse Emr Mkt Etf (VWO)
SPDR Portfolio Developed World Ex-US ETF Portfolio Devlpd (SPDW)
Citigroup Com New (C)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)

View all positions for YANKCOM Partnership

Top funds holding AstraZeneca

PRIMECAP Management Company
Wellington Management Company
Capital Research and Management Company - Division 3
FMR
Fisher Investments
Franklin Resources
Sanders Capital
Goldman Sachs Group
Atlantic Trust
Dimensional Fund Advisors
Holocene Advisors
BlackRock
Ameriprise Financial
Robeco Investment Management
Citadel Advisors

View all funds holding AstraZeneca